These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30008709)

  • 1. Interplay Between Membrane Permeability and Enzymatic Barrier Leads to Antibiotic-Dependent Resistance in
    Nicolas-Chanoine MH; Mayer N; Guyot K; Dumont E; Pagès JM
    Front Microbiol; 2018; 9():1422. PubMed ID: 30008709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.
    Sugawara E; Kojima S; Nikaido H
    J Bacteriol; 2016 Dec; 198(23):3200-3208. PubMed ID: 27645385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin-Tazobactam and Ceftolozane-Tazobactam in Tigecycline-Non-Susceptible
    Li J; Xu Q; Ogurek S; Li Z; Wang P; Xie Q; Sheng Z; Wang M
    Infect Drug Resist; 2020; 13():4309-4319. PubMed ID: 33273833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Level Carbapenem Resistance among OXA-48-Producing
    Lumbreras-Iglesias P; Rodicio MR; Valledor P; Suárez-Zarracina T; Fernández J
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity.
    Nelson K; Hemarajata P; Sun D; Rubio-Aparicio D; Tsivkovski R; Yang S; Sebra R; Kasarskis A; Nguyen H; Hanson BM; Leopold S; Weinstock G; Lomovskaya O; Humphries RM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals.
    Castanheira M; Doyle TB; Mendes RE; Sader HS
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of OqxAB efflux pumps, OmpK35 and OmpK36 porins in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates from Iran.
    Taherpour A; Hashemi A
    Hippokratia; 2013 Oct; 17(4):355-8. PubMed ID: 25031516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae.
    Shields RK; Clancy CJ; Hao B; Chen L; Press EG; Iovine NM; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5793-7. PubMed ID: 26169413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    Doumith M; Ellington MJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.
    Pagès JM; Peslier S; Keating TA; Lavigne JP; Nichols WW
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1349-59. PubMed ID: 26666933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Porins and bla
    Balabanian G; Rose M; Manning N; Landman D; Quale J
    Microb Drug Resist; 2018 Sep; 24(7):877-881. PubMed ID: 29782237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey.
    Hasdemir UO; Chevalier J; Nordmann P; Pagès JM
    J Clin Microbiol; 2004 Jun; 42(6):2701-6. PubMed ID: 15184455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.
    Bialek S; Lavigne JP; Chevalier J; Marcon E; Leflon-Guibout V; Davin A; Moreau R; Pagès JM; Nicolas-Chanoine MH
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4373-8. PubMed ID: 20679507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.